- Adaptive Biotechnologies (ADPT, Financial) to release Q2 2025 financial results on August 5, 2025.
- Conference call scheduled for 1:30 PM PT / 4:30 PM ET on the same day.
- Webcast and replay available via the company's website.
Adaptive Biotechnologies Corporation (ADPT), a leading biotech firm specializing in adaptive immune system applications, has announced that it will publish its financial results for the second quarter of 2025 post-market close on August 5, 2025. As part of the announcement, company management will conduct a live webcast and conference call at 1:30 PM Pacific Time / 4:30 PM Eastern Time to discuss the results in detail.
Investors interested in the live audio of the webcast can access it through the "Investors" section of Adaptive Biotechnologies' website at www.adaptivebiotech.com. For those unable to attend the live session, a replay will be made available within 24 hours after the event takes place.
Adaptive Biotechnologies utilizes its proprietary immune medicine platform to develop clinical diagnostics and therapeutic products aimed at diseases such as cancer and autoimmune disorders. The company's innovative approach focuses on decoding the enormous potential of the adaptive immune system to improve patient diagnostics and treatment.
